Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer
Daniel Dorbin, Juliannie Herrera, Raven Davidson, Naveenkumar Chandrashekar, Gabrielle Scheuber, Priyanga Jayakrishnan, Christabelle Rajesh, Grayson Johnson, Jason Yuan, Matthew Sochor, John Fairbanks Langenheim, Mohammed Aldakkak, Charles Messerly, Jacquelyn Wittmann, Anikó Szabó, , Thomas McFall
This paper identifies allele-specific resistance mechanisms to daraxonrasib in pancreatic cancer and demonstrates how these guide effective salvage therapies.
bioRxiv · Jul 10, 2026 · PreprintCancer Biology